C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 473/06 (2006.01) A61K 31/495 (2006.01) A61P 3/00 (2006.01) A61P 9/00 (2006.01) C07D 473/04 (2006.01)
Patent
CA 2626723
The present invention relates to compounds1 of formula (I) which are xanthine derivatives, processes for the manufacture of said derivatives, pharmaceutical formulations containing these, compounds and the use of the compounds in therapy, for example, in the treatment of diseases where under-activation of the HM74A receptor contributes to the disease or where activation of the receptor will be beneficial.
La présente invention concerne des composés de formule (I) qui sont des dérivés de la xanthine, des procédés pour la fabrication desdits dérivés, des formulations pharmaceutiques les contenant, des composés et l~utilisation des composés pour une thérapie, par exemple, pour traiter des maladies dans lesquelles la sous activation du récepteur HM74A contribue à la maladie ou lorsque l~activation du récepteur peut être bénéfique.
Hatley Richard Jonathan Daniel
Mason Andrew Mcmurtrie
Pinto Ivan Leo
Glaxosmithkline Llc
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
LandOfFree
Xanthine derivatives as selective hm74a agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Xanthine derivatives as selective hm74a agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthine derivatives as selective hm74a agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1649471